Revvity Total Liabilities 2010-2024 | RVTY

Revvity total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Revvity total liabilities for the quarter ending September 30, 2024 were $5.555B, a 12.51% decline year-over-year.
  • Revvity total liabilities for 2023 were $5.692B, a 15.64% decline from 2022.
  • Revvity total liabilities for 2022 were $6.747B, a 14.15% decline from 2021.
  • Revvity total liabilities for 2021 were $7.859B, a 86.03% increase from 2020.
Revvity Annual Total Liabilities
(Millions of US $)
2023 $5,692
2022 $6,747
2021 $7,859
2020 $4,225
2019 $3,725
2018 $3,391
2017 $3,588
2016 $2,123
2015 $2,056
2014 $2,085
2013 $1,952
2012 $1,962
2011 $2,013
2010 $1,284
2009 $1,430
Revvity Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $5,555
2024-03-31 $5,586
2023-12-31 $5,692
2023-09-30 $5,727
2023-06-30 $6,349
2023-03-31 $6,604
2022-12-31 $6,747
2022-09-30 $6,759
2022-06-30 $7,023
2022-03-31 $7,662
2021-12-31 $7,859
2021-09-30 $7,941
2021-06-30 $4,500
2021-03-31 $4,760
2020-12-31 $4,225
2020-09-30 $3,634
2020-06-30 $3,669
2020-03-31 $3,625
2019-12-31 $3,725
2019-09-30 $3,782
2019-06-30 $3,692
2019-03-31 $3,448
2018-12-31 $3,391
2018-09-30 $3,290
2018-06-30 $3,441
2018-03-31 $3,571
2017-12-31 $3,588
2017-09-30 $2,203
2017-06-30 $2,166
2017-03-31 $2,132
2016-12-31 $2,123
2016-09-30 $2,169
2016-06-30 $2,106
2016-03-31 $2,161
2015-12-31 $2,056
2015-09-30 $1,977
2015-06-30 $1,962
2015-03-31 $1,968
2014-12-31 $2,085
2014-09-30 $1,824
2014-06-30 $1,881
2014-03-31 $1,942
2013-12-31 $1,952
2013-09-30 $1,932
2013-06-30 $1,951
2013-03-31 $1,974
2012-12-31 $1,962
2012-09-30 $1,948
2012-06-30 $1,916
2012-03-31 $1,982
2011-12-31 $2,013
2011-09-30 $1,457
2011-06-30 $1,639
2011-03-31 $1,398
2010-12-31 $1,284
2010-09-30 $1,541
2010-06-30 $1,502
2010-03-31 $1,396
2009-12-31 $1,430
2009-09-30 $1,457
2009-06-30 $1,372
2009-03-31 $1,346
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00